Nara K, Taguchi S, Buti S, et al. Associations of concomitant medications with immune-related adverse events and survival in advanced cancers treated with immune checkpoint inhibitors: a comprehensive pan-cancer analysis. J ImmunoTher Cancer 2024;12:e008806. doi: 10.1136/jitc-2024-008806

This article has been corrected since it was first published. Numbers in the Patients’ characteristics section have been revised as follows: melanoma (n= 43->40); biliary tract cancer (n=23->25); pancreatic cancer (n=4->2); Merkel cell carcinoma (n=0->3). The Acknowledgements section has also been updated to credit the involvement of the relevant departments at the Graduate School of Medicine, The University of Tokyo.